Endocrinology And Metabolic

1. Graves’ Disease : Introduction
2. Hyperparathyroidism : Comparative Overview of types( Primary, Secondary, and Tertiary )
3. Sodium-glucose co-transporter-2 (SGLT2) inhibitors in adults with type 2 diabetes
4.Acromegaly
5.Acromegaly- quick review card
6.ACTH-Secreting Tumours : RCGP Curriculum Context
7.ADA-EASD-guideline on management of Type 2 Diabetes
8.Addison's disease
9.Addison’s disease
10.Adrenal gland- Quick revision card
11.Adrenal insufficiency : When to suspect ( NICE guidance summary )
12.Adrenal insufficiency ( Hypoadrenalism )
13.Amiodarone and thyroid function
14.Androgen Insensitivity Syndrome (AIS)
15.Association of Diabetes with Other Immunological Conditions
16.Bone Profile and calcium metabolism : a clinician's guide
17.Calcium Low ( Hypocalcemia ) : Acute Management
18.Carbimazole
19.CKD and Calcium Metabolism: Key Points for GP's
20.Congenital adrenal hyperplasia – Quick review chart
21.Cushing’s syndrome – Quick revision card
22.Delayed puberty -Quick review chart
23.Diabetes – complications quick review chart
24.Diabetes : diagnosis
25.Diabetes : Gestational ( NICE recommendations summary )
26.Diabetes : types ( Overview )
27.Diabetes foot check
28.Diabetes Ketoacidosis ( DKA )
29.Diabetes Type 2 : Diagnosis
30.Diabetes- Macrovascular complications
31.Diabetes-Alphabet Strategy
32.Diabetes-prescribing in renal impairment
33.Diabetes-Referral guide
34.Diabetic Eye Screening Programme – NHS
35.Diabetic foot infection – quick review chart
36.Diabetic foot problem – risk assessment
37.Diabetic foot ulcer – Quick review chart
38.Diabetic Ketoacidosis (DKA) ; Ketones
39.Emergency management of hyperglycemia- RACGP_ADS
40.Endocrine Manifestations of Non-Endocrine Diseases
41.Flushing patient
42.Glucagon-like peptide ( GLP-1 ) receptor agonists ( GLP-1 RAs )
43.Goiter
44.Haemochromatosis & Disorders of Iron Metabolism: GP Guide
45.Hashimoto thyroiditis
46.Hirsutism
47.Hyperaldosteronism – Quick revision chart
48.Hypercalcaemia – raised calcium
49.Hypercalcemia ( Raised calcium ) : Acute management
50.Hyperhidrosis – Quick review chart
51.Hyperkalaemia- Raised Potassium
52.Hyperlipidaemias in Primary Care: Familial and Acquired Causes, Diagnosis, and Management
53.Hypernatraemia- Raised sodium
54.Hyperosmolar hyperglycemic syndrome ( HHS )
55.Hyperparathyroidism – Quick revision card
56.Hyperprolactinemia
57.Hyperthyroidism
58.Hyperuricemia
59.Hypocalcemia-Low calcium
60.Hypoglycemia – quick revision card
61.Hypoglycemic agents : overview
62.Hypokalaemia in adults- treatment
63.Hypokalaemia- Low potassium
64.Hypomagnesemia
65.Hyponatremia ( Low Sodium )
66.Hyponatremia ( Low Sodium ) ACUTE : Management in primary care
67.Hypoparathyroidism -Quick revision chart
68.Hypopituitarism -Quick review card
69.Hypothalamic Causes of Hormonal Disturbances Understanding Central Dysregulation of Endocrine Function
70.Hypothyroidism
71.Impaired Fasting Glucose (IFG) : Introduction
72.Impaired Glucose Tolerance (IGT) – Guide for primary care clinicians
73.Inherited Metabolic Diseases in Primary Care
74.Injectable Medications for Diabetes Management GLP-1 Agonists & Insulin: Regimens, Administration, and Dosages
75.Insulin chart
76.Insulin Resistance – GP Guide
77.Insulin Types, Brand Names, Manufacturers, and Delivery Devices
78.Introduction: Pre-diabetes in Primary Care
79.Investigating Suspected Thyroid Dysfunction
80.Ketone testing interpretation
81.Latent autoimmune diabetes in adults (LADA) : a guide for GPs
82.Liraglutide Use for Managing Overweight and Obesity: Eligibility and Rationale
83.Low phosphate
84.Male hypogonadism
85.Metformin -Quick revision card
86.Multiple Endocrine Neoplasia -Quick review card
87.Neck lumps : differentials
88.Oral Glucose Tolerance Test (OGTT)
89.Osteomalacia and Rickets – Quick revision card
90.Osteoporosis
91.Osteoporosis : Bisphosphonates
92.Osteoporosis : Fragility fracture risk score interpretation
93.Pagets disease of bone – quick review card
94.Pheochromocytoma
95.Pheochromocytoma : A review
96.Pituitary adenoma – Quick review card
97.Pituitary apoplexy – Quick review chart
98.Polyuria and polydipsia
99.Potassium
100.Precocious puberty – Quick review card
101.Primary Hyperparathyroidism
102.Primary hyperparathyroidism – Quick review chart
103.Primary hypothyroidism -management and follow up
104.Rickets versus osteomalacia
105.Sick euthyroid sydrome (The Non-Thyroidal Illness Syndrome)
106.Sodium Glucose Cotransporter -2 (SGLT2 ) Inhibitors -Gliflozins
107.Sodium-Glucose Cotransporter Inhibitors ( SGLT2 )
108.Subclinical hyperthyroidism
109.Subclinical hypothyroidism : diagnosis and management in adults, summary ( NICE )
110.Testosterone : Raised ( total ) causes
111.Testosterone deficiency syndrome
112.Thyroid Cancer
113.Thyroid Function Tests : Interpretation
114.Thyroid hormones : Overview
115.Thyroidits
116.Type 1 diabetes – suspecting in children 0-19 pathway
117.Type 2 diabetes
118.Type 2 diabetes – Gastroparesis
119.Type 2 diabetes – Insulin therapy
120.Type 2 diabetes – self monitoring of blood glucose ( SMBG )
121.Type 2 diabetes : detailed stepwise treatment recommendations ( NICE )
122.Type 2 diabetes & CKD : SGLT2 inhibitors
123.Type 2 Diabetes in Adults : Management NICE guidance June 2022
124.Type 2 Diabetes Management : Main Classes of Medications
125.Type 2 Diabetes NICE targets
126.Vitamin D deficiency
127.Vitamin D Deficiency : Management
128.WHO Diagnostic criteria diabetes